Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020)

NCT05934292 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

NCT05624723 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment

NCT05200286 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

NCT02894905 ·Status: COMPLETED ·Phase: PHASE1

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

NCT01846468 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

NCT03913000 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function

NCT05094934 ·Status: TERMINATED ·Phase: PHASE1

A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)

NCT06468826 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetics and Safety Study in Subjects With Renal Impairment

NCT01452828 ·Status: COMPLETED ·Phase: PHASE1

PK of Serelaxin in Severe Renal Impairment and ESRD

NCT01875523 ·Status: COMPLETED ·Phase: PHASE1

A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

NCT07165015 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

NCT02320045 ·Status: COMPLETED ·Phase: PHASE1

Lorlatinib Renal Impairment Study

NCT03542305 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)

NCT00648167 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

NCT04859439 ·Status: COMPLETED ·Phase: PHASE1

A Renal Impairment Study for PF-04965842

NCT03660241 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

NCT01359579 ·Status: TERMINATED ·Phase: PHASE1

Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance

NCT01237899 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment

NCT05489614 ·Status: COMPLETED ·Phase: PHASE1

PF-04634817 Renal Impairment Study

NCT01791855 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

NCT06962774 ·Status: COMPLETED ·Phase: PHASE1

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

NCT03844555 ·Status: COMPLETED ·Phase: PHASE1

The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

NCT01832103 ·Status: WITHDRAWN ·Phase: PHASE1

Study of Suramin in Subjects With Furosemide-Resistant AKI

NCT04496596 ·Status: UNKNOWN ·Phase: PHASE2

Plazomicin Study in ESRD Patients Receiving IHD

NCT04699656 ·Status: COMPLETED ·Phase: PHASE1